Pharmafile Logo
Pharmafocus logo
Advanced Search

Texas mandates the wearing of facemasks in public

July 3, 2020
Medical Communications COVID-19, coronavirus

Texas becomes the latest state in the US to mandate the wearing of facemasks in public, as COVID-19 cases skyrocket …

News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronaviurs, top 10

Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s …

News
shutterstock_38078521

EUSA Pharma gets FDA green light to evaluate IL-6 inhibitor siltuximab in COVID-19 patients

July 2, 2020
Research and Development COVID-19, Eusa Pharma, siltuximab

Efforts push on to discover an effective treatment for COVID-19 in more than 100 different drug candidates worldwide. EUSA Pharma …

News
london-railway-station-travel

COVID-19 immunity may be more widespread than previously thought, new study suggests

July 2, 2020
Business Services coronaviurs, covid-29, herd immunity

Coronavirus immunity in the world’s population may be more widespread than initially thought, even in those who have tested negative …

News
ebola_vaccine

European Commission announces approval for Janssen’s Ebola vaccine

July 2, 2020
Business Services EC, Ebola, Ebola Vaccines

Johnson & Johnson announced that the European Commission has granted Marketing Authorisation for its Janssen Ebola vaccine. Two Marketing Authorisation …

News
novo

Drug industry suing to overturn Minnesota insulin affordability law

July 2, 2020
Business Services diabetes, insulin, type 1, type 2

The drug industry is suing to overturn a Minnesota law that requires companies to provide emergency insulin to diabetics who …

News
leicester_copyright_mat_fascione

UK Government accused of withholding Pillar 2 COVID-19 data which show Leicester had 10 times more cases than reported pre-lockdown

July 1, 2020
Medical Communications, Research and Development, Sales and Marketing COVID-19, UK

The UK Government warned when relaxing lockdown measures on 23 June that it would not hesitate to lock down any …

News

FDA approves Pfizer and Merck KGaA’s Bavencio for maintenance of advanced bladder cancer

July 1, 2020
Research and Development, Sales and Marketing Bavencio FDA, EMD Serono, Merck, Pfier

The FDA has moved to approve Bavencio (avelumab), developed by Pfizer and EMD Serono, the biopharma arm of Merck KGaA, …

News
takeda_world

Takeda partners up with Carmine Therapeutics to develop and market rare disease candidates

July 1, 2020
Research and Development Takeda Carmine, partnership, pharma

Takeda has linked up with Carmine Therapeutics in a new partnership to discover, develop and bring to market new non-viral …

News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

July 1, 2020
Research and Development COVID-19, coronavirus

COVID-19 vaccines dominate this week’s news cycle, with Vaxart announcing the selection of its lead candidate for COVID-19 by Operation …

News
vacinnenenen

US buys most of the world’s stock of COVID-19 drug remdesivir

July 1, 2020
Research and Development COVID-19, coronavirus

The US has bought most of the world’s stock of the drug remdesivir which is one of the only drugs …

News
fda

FDA says COVID-19 vaccine would need to be at least 50% effective to be approved

July 1, 2020
Research and Development COVID-19, FDA, coronavirus

The FDA announced that any COVID-19 vaccine that gets approval must show that it is at least 50% more effective …

News
vaccinessssssssssssssssssss

India to go ahead with human trials of COVID-19 vaccine in July

June 30, 2020
Manufacturing and Production COVID-19, Vaccine, coronavirus

A trial of a new Indian made vaccine will begin testing in humans from July. The vaccine is called Covaxin …

News
roche

Roche’s Phesgo combo secures US approval for metastatic HER2-positive breast cancer

June 30, 2020
Manufacturing and Production, Sales and Marketing FDA, Phesgo, Roche, US, breast cancer

The FDA has awarded marketing authorisation in the US to Roche’s Phesgo, a combination of subcutaneously injected Herceptin (trastuzumab) with …

News

New swine flu with pandemic potential identified in China

June 30, 2020
Manufacturing and Production flu, flu pandemic, swine flu

A new strain of flu has emerged in pigs in China, with scientists warning it has pandemic potential. Researchers call …

News
pharmafocus_july-august_2020_cover

The July/August 2020 issue of Pharmafocus is available to read free online now!

June 30, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Pharmafocus, pharma

The July/August 2020 issue of Pharmafocus is available to read free online now!

News
remsss

Gilead facing criticism for charging $2,340 for remdesivir

June 30, 2020
Manufacturing and Production COVID-19, coronavirus

Gilead has announced that it will charge $2,340 for a 5 day treatment course of remdesivir, a drug that has …

News

NICE knocks back Janssen’s Zytiga combo for newly diagnosed, hormone-sensitive metastatic prostate cancer.

June 29, 2020
Sales and Marketing

Drug watchdog NICE has chosen to stick with its earlier decision not to recommend Janssen’s Zytiga (abiraterone aetate), combined with …

News
fdaoutsideweb

FDA rejects Allergan’s Abicipar pegol for neovascular age-related macular degeneration over benefit/risk concerns

June 29, 2020
Sales and Marketing AbbVie, Allergan, FDA, pharma

The FDA has moved to reject Allergan’s vascular endothelial growth factor (VEGF) factor A inhibitor, Abicipar pegol, as treatment for …

News

Vaxart announces its COVID-19 vaccine has been selected by US Operation Warp Speed programme

June 29, 2020
Sales and Marketing COVID-19, COVID-19 vaccine, coronavirus, coronavirus vaccine

Vaxart has announced the selection of its lead vaccine candidate for COVID-19 by Operation Warp Speed, a program to find …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026